GB0524589A
GB0524589D0
(en)
|
2005-12-02 |
2005-12-02 |
Chemical compounds
|
BRPI0613570A
BRPI0613570B8
(en)
|
2005-07-09 |
2006-07-03 |
compound, pharmaceutical composition and use of a compound or a pharmaceutically acceptable salt thereof
|
BRPI0622261-7A
BRPI0622261A2
(en)
|
2005-07-09 |
2006-07-03 |
compound, pharmaceutical composition, use of a compound or a pharmaceutically acceptable salt thereof, and process for the preparation of a compound
|
NZ575513A
NZ575513A
(en)
|
2005-07-09 |
2006-07-03 |
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
EP10174130A
EP2301929A1
(en)
|
2005-07-09 |
2006-07-03 |
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
NZ575512A
NZ575512A
(en)
|
2005-07-09 |
2006-07-03 |
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
NZ575514A
NZ575514A
(en)
|
2005-07-09 |
2006-07-03 |
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
AU2006268406A
AU2006268406C1
(en)
|
2005-07-09 |
2006-07-03 |
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
JP2008520936A
JP4651714B2
(en)
|
2005-07-09 |
2006-07-03 |
Heteroarylbenzamide derivatives for use as GLK activators in the treatment of diabetes
|
PCT/GB2006/002471
WO2007007041A1
(en)
|
2005-07-09 |
2006-07-03 |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
BRPI0622262-5A
BRPI0622262A2
(en)
|
2005-07-09 |
2006-07-03 |
compound, pharmaceutical composition, use of a compound or a pharmaceutically acceptable salt thereof, and process for the preparation of a compound
|
KR1020117015352A
KR20110084339A
(en)
|
2005-07-09 |
2006-07-03 |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
KR1020087002533A
KR101346902B1
(en)
|
2005-07-09 |
2006-07-03 |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
CN200810169877.8A
CN101445505B
(en)
|
2005-07-09 |
2006-07-03 |
The heteroaryl benzamide derivatives of GLK activator is used as in treatment diabetes
|
EP10174128A
EP2301935A1
(en)
|
2005-07-09 |
2006-07-03 |
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
ES06755703T
ES2397648T3
(en)
|
2005-07-09 |
2006-07-03 |
Heteroarylbenzamide derivatives for use as GLK activators in the treatment of diabetes
|
NZ564608A
NZ564608A
(en)
|
2005-07-09 |
2006-07-03 |
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
CA2614746A
CA2614746C
(en)
|
2005-07-09 |
2006-07-03 |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
EP06755703A
EP1902052B1
(en)
|
2005-07-09 |
2006-07-03 |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
MX2008000172A
MX2008000172A
(en)
|
2005-07-09 |
2006-07-03 |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes.
|
RU2008101927/04A
RU2415141C2
(en)
|
2005-07-09 |
2006-07-03 |
Heteroarylbenzamide derivatives applied as glk activators in diabetes treatment
|
EP10174132A
EP2305674A1
(en)
|
2005-07-09 |
2006-07-03 |
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
US11/995,077
US7642259B2
(en)
|
2005-07-09 |
2006-07-03 |
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
MYPI20063239A
MY147749A
(en)
|
2005-07-09 |
2006-07-06 |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
UY29656A
UY29656A1
(en)
|
2005-07-09 |
2006-07-07 |
AMINO BENZOIL HETEROCICLILOS COMPOUND GROUPS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
|
ARP060102937A
AR055074A1
(en)
|
2005-07-09 |
2006-07-07 |
DERIVATIVES OF HETEROARIL BENZAMIDAS AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES. PROCESSES OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS.
|
TW095124869A
TW200730174A
(en)
|
2005-07-09 |
2006-07-07 |
Chemical compounds
|
SA06270215A
SA06270215B1
(en)
|
2005-07-09 |
2006-07-09 |
Heteroaryl Benzamide Derivatives for Use As GLK Activators in the Treatment of Diabetes
|
IL188059A
IL188059A0
(en)
|
2005-07-09 |
2007-12-11 |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
NO20076658A
NO20076658L
(en)
|
2005-07-09 |
2007-12-28 |
Heteroberl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
EC2008008164A
ECSP088164A
(en)
|
2005-07-09 |
2008-02-08 |
DERIVATIVES OF HETEROARIL BENZAMIDA FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES
|
HK08106758.1A
HK1116769A1
(en)
|
2005-07-09 |
2008-06-18 |
Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
|
US12/202,800
US7642263B2
(en)
|
2005-07-09 |
2008-09-02 |
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
US12/203,324
US7842694B2
(en)
|
2005-07-09 |
2008-09-03 |
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
US12/256,254
US7977328B2
(en)
|
2005-07-09 |
2008-10-22 |
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
JP2009157639A
JP2009215320A
(en)
|
2005-07-09 |
2009-07-02 |
Heteroarylbenzamide derivative used for glk-activator in diabetic treatment
|
JP2009157655A
JP4651729B2
(en)
|
2005-07-09 |
2009-07-02 |
Heteroarylbenzamide derivatives for use as GLK activators in the treatment of diabetes
|
JP2009157686A
JP2009263390A
(en)
|
2005-07-09 |
2009-07-02 |
Heteroaryl benzamide derivative for use as glk activator in treatment of diabetes
|
AU2010235903A
AU2010235903B2
(en)
|
2005-07-09 |
2010-10-19 |
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
|
RU2010149302/04A
RU2010149302A
(en)
|
2005-07-09 |
2010-12-03 |
Heteroarylbenzamide derivatives for use as GLK activators in the treatment of diabetes
|
IL215102A
IL215102A0
(en)
|
2005-07-09 |
2011-09-12 |
A heteroaryl benzamide derivative and a pharmaceutical composition containing it
|